Table 3.
V2.0 assay (%) | |||||
---|---|---|---|---|---|
PAβ V2.0 assay | Intra-assay (n = 6) | Inter-assay (n = 5) | |||
Aβ1–40 | pg/mL | Aβ1–38 IS Normalized | Aβ1–40 IS Normalized | Aβ1–38 IS Normalized | Aβ1–40 IS Normalized |
Level 1 | 37.5 | 6.5 | 5.5 | 3.4 | 1.8 |
Level 2 | 146.4 | 7.9 | 7.0 | 5.9 | 2.6 |
Level 3 | 382.5 | 5.9 | 4.6 | 2.3 | 1.7 |
Aβ1–42 | pg/mL | Aβ1–38 IS Normalized | Aβ1–42 IS | Aβ1–38 IS Normalized | Aβ1–42 IS Normalized |
Level 1 | 82.8 | 6.8 | 4.6 | 4.3 | 4.8 |
Level 2 | 49.5 | 5.6 | 4.9 | 5.8 | 4.2 |
Level 3 | 13.9 | 4.1 | 5.3 | 4.2 | 3.0 |
Aβ1–42/Aβ1–40 | Aβ1–38 IS Normalized | Aβ1–40 IS and Aβ1–42 IS Normalized | Aβ1–38 IS Normalized | Aβ1–40 IS and Aβ1–42 IS Normalized | |
Level 1 | 2.208 | 2.2 | 2.3 | 3.2 | 3.9 |
Level 2 | 0.338 | 5.2 | 5.1 | 6.6 | 6.6 |
Level 3 | 0.036 | 4.5 | 4.4 | 5.9 | 4.9 |
V1.0 assay (%) | |||||
PAβ V1.0 assay | Intra-assay (n = 6) | Inter-assay (n = 5) | |||
Aβ1–40 | pg/mL | Aβ1–38 IS Normalized | Aβ1–40 IS Normalized | Aβ1–38 IS Normalized | Aβ1–40 IS Normalized |
Level 1 | 37.5 | 3.4 | 1.9 | 4.9 | 0.8 |
Level 2 | 146.4 | 3.7 | 3.4 | 4.7 | 2.7 |
Level 3 | 382.5 | 6.7 | 4.4 | 2.6 | 3.0 |
Aβ1–42 | pg/mL | Aβ1–38 IS Normalized | Aβ1–42 IS Normalized | Aβ1–38 IS Normalized | Aβ1–42 IS Normalized |
Level 1 | 82.8 | 3.2 | 2.2 | 4.3 | 0.7 |
Level 2 | 49.5 | 2.8 | 3.4 | 5.3 | 2.6 |
Level 3 | 13.9 | 7.3 | 5.9 | 5.5 | 4.8 |
Aβ1–42/Aβ1–40 | Aβ1–38 IS Normalized | Aβ1–40 IS and Aβ1–42 IS Normalized | Aβ1–38 IS Normalized | Aβ1–40 IS and Aβ1–42 IS Normalized | |
Level 1 | 2.208 | 1.5 | 2.6 | 2.0 | 2.6 |
Level 2 | 0.338 | 2.3 | 2.0 | 2.4 | 3.2 |
Level 3 | 0.036 | 4.2 | 4.1 | 5.3 | 4.6 |